The global oxygen therapy devices market size was valued at USD 39.09 billion in 2025 and is projected to grow from USD 41.69 billion in 2026 to USD 69.84 billion by 2034, registering a CAGR of 6.66% during the forecast period from 2026 to 2034. North America dominated the oxygen therapy devices market with a market share of 38.5% in 2025.
Oxygen therapy devices are medical equipment designed to deliver supplemental oxygen to patients experiencing respiratory disorders or low blood oxygen levels. These devices include oxygen concentrators, cylinders, liquid oxygen systems, masks, and nasal cannulas used in hospitals, clinics, emergency care, and home healthcare settings. Demand is driven by the rising prevalence of chronic respiratory diseases, an aging population, increasing home-based care, and advancements in portable oxygen delivery technologies.
Download a Free Sample To learn more about this report,
Increasing Adoption of Portable and Lightweight Oxygen Therapy Devices
The oxygen therapy devices market is increasingly focused on portable and lightweight technologies designed to improve patient mobility and convenience. Manufacturers are developing compact oxygen concentrators and delivery systems with improved battery efficiency, reduced weight, and more user-friendly designs. This product innovation is enabling patients requiring supplemental oxygen to maintain greater mobility and flexibility during daily activities.
In March 2025, medical device manufacturers continued advancing lightweight and portable oxygen therapy devices designed to improve mobility, battery performance, and patient convenience.
Growing Integration of Smart Monitoring and Connected Respiratory Care Technologies
Oxygen therapy devices are increasingly incorporating digital connectivity and monitoring capabilities to support more effective respiratory care management. Connected systems can help healthcare providers and caregivers monitor device usage and treatment-related information remotely. The growing integration of digital technologies is supporting the development of more connected and data-driven respiratory care ecosystems.
In July 2025, respiratory care technology providers continued developing connected monitoring capabilities designed to support remote management of oxygen therapy and long-term respiratory care.
Rising Prevalence of Chronic Respiratory Diseases
The growing prevalence of chronic respiratory conditions, including chronic obstructive pulmonary disease and other disorders affecting lung function, is increasing demand for oxygen therapy. Many patients require supplemental oxygen to manage reduced blood oxygen levels and support long-term respiratory care. The expanding burden of chronic respiratory diseases therefore provides a fundamental driver for the oxygen therapy devices market.
In April 2025, healthcare organizations continued emphasizing the growing burden of chronic respiratory diseases and the increasing need for effective long-term respiratory care.
High Cost of Advanced Portable Oxygen Therapy Devices
Advanced portable oxygen concentrators and specialized oxygen delivery systems can involve substantial acquisition and maintenance costs. Battery technology, compact engineering, servicing requirements, and replacement components can increase the overall cost of ownership. These affordability challenges may limit access to advanced oxygen therapy devices, particularly among price-sensitive patients and healthcare providers.
In June 2025, healthcare providers and patients continued managing affordability challenges associated with advanced portable respiratory care technologies.
Expansion of Home Healthcare and Remote Patient Care Services
The continued growth of home healthcare services is creating significant opportunities for oxygen therapy device manufacturers. Healthcare systems are increasingly supporting care models that enable eligible patients to receive treatment and monitoring outside hospitals. This expansion creates demand for reliable oxygen delivery equipment designed for home use and integration with remote care services.
In September 2025, healthcare providers continued expanding home-based care and remote patient-management services, supporting opportunities for medical devices designed for long-term treatment outside hospital settings.
Ensuring Safe and Reliable Oxygen Delivery Across Different Care Settings
Oxygen therapy requires appropriate device operation, maintenance, and monitoring to ensure patients receive the prescribed level of oxygen safely. Equipment malfunction, incorrect usage, and inconsistent maintenance can affect treatment reliability. Ensuring device safety, dependable performance, and proper patient education across hospitals, clinics, and home-care environments remains a significant challenge for market participants.
In November 2025, respiratory care providers continued emphasizing equipment maintenance, patient education, and safe oxygen administration practices to support reliable long-term oxygen therapy.
Oxygen Source Equipment Segment Dominated the Market with 68.4% Share in 2025
The oxygen source equipment segment dominated the global oxygen therapy devices market with a 68.4% share in 2025, driven by the increasing prevalence of chronic respiratory disorders and the growing demand for reliable long-term oxygen therapy. The widespread use of oxygen generation and storage devices across hospitals, emergency care settings, and home healthcare continues to strengthen the segment's leading position.
The oxygen delivery devices segment is witnessing steady growth as healthcare providers increasingly adopt advanced delivery systems to improve patient comfort and treatment efficiency. Rising demand for personalized oxygen therapy, coupled with the growing aging population and increasing incidence of respiratory illnesses, continues to support the expansion of this segment.
Continuous technological advancements in portable oxygen systems, smart monitoring capabilities, and energy-efficient devices are expected to further accelerate market growth. Increasing investments in respiratory care infrastructure and home-based treatment solutions continue to create opportunities across both product categories.
Request Customizationto receive a tailored report.
Oxygen Concentrators Segment Dominated the Market with 39.8% Share in 2025
The oxygen concentrators segment dominated the oxygen source equipment market with a 39.8% share in 2025, owing to their ability to provide a continuous oxygen supply without frequent refilling. Their ease of use, lower operating costs, and growing adoption in home healthcare settings have made them the preferred choice for long-term oxygen therapy.
The oxygen cylinders and PAP devices segments are witnessing steady growth as healthcare facilities continue to rely on cylinders for emergency oxygen supply while the increasing prevalence of sleep-related breathing disorders is driving demand for PAP devices. At the same time, liquid oxygen devices are gaining wider acceptance among patients requiring high-flow oxygen therapy due to their portability and higher oxygen storage capacity.
Within oxygen cylinders, fixed cylinders continue to account for the larger share because of their extensive use in hospitals and healthcare facilities, while portable cylinders are gaining popularity for ambulatory patients. In oxygen concentrators, fixed units remain widely used for continuous therapy, whereas portable concentrators are expanding rapidly due to their lightweight design and greater patient mobility. Among PAP devices, CPAP continues to lead the segment, while APAP is witnessing faster adoption because of its automatic pressure adjustment capabilities, and Bi-PAP devices remain an important option for patients requiring advanced respiratory support.
Nasal Cannula Segment Dominated the Market with 27.4% Share in 2025
The nasal cannula segment dominated the oxygen delivery devices market with a 27.4% share in 2025, driven by its high patient comfort, ease of use, and suitability for long-term oxygen therapy. Its widespread adoption across hospitals, outpatient facilities, and home healthcare continues to support the segment's leading position.
The oxygen masks, Venturi masks, and CPAP masks segments are witnessing steady growth due to increasing demand for controlled oxygen delivery across different clinical conditions. Meanwhile, non-rebreather masks and bag valve masks continue to play an essential role in emergency medicine and critical care, where rapid oxygen administration is required.
The others segment is also expanding steadily as manufacturers introduce specialized oxygen delivery interfaces designed for pediatric care, high-flow oxygen therapy, and patient-specific clinical needs. Ongoing innovations focused on improving patient comfort, oxygen efficiency, and ease of use are expected to support growth across all oxygen delivery device categories.
Chronic Obstructive Pulmonary Disease Segment Dominated the Market with 34.2% Share in 2025
The chronic obstructive pulmonary disease (COPD) segment dominated the global oxygen therapy devices market with a 34.2% share in 2025, supported by the growing prevalence of chronic respiratory disorders and the increasing need for long-term oxygen therapy. Rising aging populations, smoking-related illnesses, and improved diagnosis rates continue to drive demand for oxygen therapy devices in COPD management.
The obstructive sleep apnea, asthma, and pneumonia segments are witnessing steady growth as awareness of respiratory health increases and more patients receive timely diagnosis and treatment. Growing adoption of PAP devices and home oxygen therapy solutions is contributing significantly to the expansion of these application areas.
The respiratory distress syndrome, cystic fibrosis, and others segments are also growing steadily due to rising demand for specialized respiratory care across neonatal, pediatric, and adult patient populations. Continuous improvements in respiratory support technologies and expanding access to advanced healthcare services are expected to sustain long-term growth across these applications.
Home Healthcare Segment Dominated the Market with 61.3% Share in 2025
The home healthcare segment dominated the global oxygen therapy devices market with a 61.3% share in 2025, driven by the increasing preference for home-based treatment among patients with chronic respiratory diseases. Growing availability of portable oxygen therapy devices, reduced hospitalization costs, and improving reimbursement support continue to strengthen demand in this segment.
The non-home healthcare segment is witnessing steady growth as hospitals, specialty clinics, rehabilitation centers, and emergency care facilities continue to invest in advanced respiratory care equipment. Rising hospital admissions related to respiratory illnesses and the need for continuous oxygen support remain key factors supporting this segment.
Increasing healthcare infrastructure development, technological advancements in respiratory devices, and the growing burden of chronic lung diseases are expected to create sustained demand across both home and non-home healthcare settings, supporting the overall expansion of the market.
Speak to an Analystto discuss market opportunities.
North America oxygen therapy devices market accounted for 38.5% of the global market, reaching USD 15.05 billion in 2025, and is projected to grow at a CAGR of 6.8% during the forecast period. Rising prevalence of chronic respiratory diseases, increasing demand for home healthcare, and growing adoption of portable oxygen delivery systems continue to drive regional market growth. Expanding healthcare infrastructure and favorable reimbursement policies are also supporting market expansion.
The U.S. market was valued at USD 12.79 billion in 2025, making it the largest contributor in North America. Growing cases of chronic obstructive pulmonary disease (COPD), increasing aging population, and rising demand for home-based respiratory care continue to strengthen market growth.
Canada's market reached USD 2.26 billion in 2025. Increasing awareness of respiratory health, expanding healthcare services, and growing adoption of advanced oxygen therapy devices continue to support steady market expansion.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe oxygen therapy devices market accounted for 27.4% of the global market, reaching USD 10.71 billion in 2025, and is expected to register a CAGR of 6.5% during the forecast period. Increasing prevalence of respiratory disorders, rising healthcare expenditure, and growing demand for long-term oxygen therapy are driving regional growth. Continuous investments in advanced medical technologies further support market development.
Germany's market accounted for USD 3.11 billion in 2025. Strong healthcare infrastructure, increasing adoption of home oxygen therapy, and growing elderly population continue to support market growth.
The UK market was valued at USD 2.14 billion in 2025. Rising demand for respiratory care services, expanding home healthcare programs, and increasing healthcare investments continue to contribute to market expansion.
Asia Pacific oxygen therapy devices market accounted for 22.8% of the global market, valued at USD 8.91 billion in 2025, and is projected to register a CAGR of 8.9% during the forecast period. Expanding healthcare infrastructure, increasing incidence of respiratory diseases, growing geriatric population, and rising awareness of home healthcare continue to accelerate regional market growth.
Japan's market generated USD 1.60 billion in 2025. Rising demand for respiratory care, increasing adoption of advanced oxygen concentrators, and a growing elderly population continue to support market growth.
China's market accounted for USD 4.63 billion in 2025, representing the largest share within Asia Pacific. Expanding healthcare facilities, increasing prevalence of chronic respiratory conditions, and growing demand for affordable oxygen therapy devices continue to drive market expansion.
Latin America oxygen therapy devices market accounted for 6.1% of the global market, reaching USD 2.38 billion in 2025, and is projected to grow at a CAGR of 7.1% during the forecast period. Improving healthcare infrastructure, increasing awareness of respiratory disease management, and rising demand for home healthcare equipment continue to support regional market growth.
Brazil's market reached USD 1.21 billion in 2025. Growing healthcare investments, expanding access to respiratory care, and increasing adoption of oxygen therapy devices continue to create growth opportunities across the country.
Middle East & Africa oxygen therapy devices market accounted for 5.2% of the global market, totaling USD 2.03 billion in 2025, and is anticipated to grow at a CAGR of 6.9% during the forecast period. Rising healthcare investments, increasing prevalence of respiratory diseases, and expanding hospital infrastructure are supporting regional market growth.
The UAE market was valued at USD 0.73 billion in 2025. Government investments in advanced healthcare infrastructure, increasing demand for respiratory care solutions, and growing adoption of home oxygen therapy continue to drive market growth.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Asia Pacific Electrocardiograph (ECG) Market Size, Share Trend Analysis by 2034
Middle East and Africa Dental Intraoral Scanners Market Size, 2034
Artificial Lung Market Size, Share, Growth, Analysis, 2034
Bronchoscopes Market Size, Share, Growth, Analysis, Report, 2034
Aesthetic Threads Market Size, Share, Growth, Forecast, 2034
Middle East And Africa Diabetes Devices Market Size and Forecast 2034
We are featured on:
sales@straitsresearch.com